These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21953823)

  • 1. Review of UV spectroscopic, chromatographic, and electrophoretic methods for the cholinesterase reactivating antidote pralidoxime (2-PAM).
    John H; Blum MM
    Drug Test Anal; 2012; 4(3-4):179-93. PubMed ID: 21953823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is PAM an effective antidote for organophosphate poisoning? There is no evidence that PAM is effective in acute organophosphorus poisoning].
    Tase C
    Chudoku Kenkyu; 2010 Mar; 23(1):36-40. PubMed ID: 20380320
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantification of pralidoxime (2-PAM) in urine by ion pair chromatography-diode array detection: application to in vivo samples from minipig.
    John H; Eddleston M; Eddie Clutton R; Worek F; Thiermann H
    Drug Test Anal; 2012; 4(3-4):169-78. PubMed ID: 22102522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of drugs for the therapy of anticholinesterase poisoning.
    John H; Blum MM
    Drug Test Anal; 2012; 4(3-4):167-8. PubMed ID: 22467252
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polarographic determination of PAM-2Cl in pharmaceutical preparations].
    Korićanac Z; Stanković B; Binenfeld Z
    Vojnosanit Pregl; 1983; 40(3):168-70. PubMed ID: 6636590
    [No Abstract]   [Full Text] [Related]  

  • 6. Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier.
    Sakurada K; Matsubara K; Shimizu K; Shiono H; Seto Y; Tsuge K; Yoshino M; Sakai I; Mukoyama H; Takatori T
    Neurochem Res; 2003 Sep; 28(9):1401-7. PubMed ID: 12938863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the therapeutic effect of 2-pyridine aldoxime methiodide (2-PAM) in mammals following organophosphorus compound-poisoning (report III): distribution and antidotal effect of 2-PAM in rats.
    Uehara S; Hiromori T; Isobe N; Suzuki T; Kato T; Miyamoto J
    J Toxicol Sci; 1993 Nov; 18(4):265-75. PubMed ID: 8295230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface modification of pralidoxime chloride-loaded solid lipid nanoparticles for enhanced brain reactivation of organophosphorus-inhibited AChE: Pharmacokinetics in rat.
    Buzyurova DN; Pashirova TN; Zueva IV; Burilova EA; Shaihutdinova ZM; Rizvanov IK; Babaev VM; Petrov KA; Souto EB
    Toxicology; 2020 Nov; 444():152578. PubMed ID: 32898602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel high-performance liquid chromatography with diode array detector method for the simultaneous quantification of the enzyme-reactivating oximes obidoxime, pralidoxime, and HI-6 in human plasma.
    Kranawetvogl T; Steinritz D; Thiermann H; John H
    Drug Test Anal; 2020 Jul; 12(7):938-947. PubMed ID: 32267631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolysis of an acetylthiocholine by pralidoxime iodide (2-PAM).
    Sakurada K; Ikegaya H; Ohta H; Akutsu T; Takatori T
    Toxicol Lett; 2006 Oct; 166(3):255-60. PubMed ID: 16971069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
    Jokanović M; Stojiljković MP
    Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of oximes HI-6 and PAM-2 applied by osmotic minipumps in quinalphos-poisoned rats.
    Bokonjić D; Jovanović D; Jokanović M; Maksimović M
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):309-18. PubMed ID: 3675088
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Mohammadi H; Jalilian J; Karimi MY; Shetab-Boushehri SV
    Sultan Qaboos Univ Med J; 2017 Aug; 17(3):e293-e300. PubMed ID: 29062551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice.
    dos Santos AA; dos Santos DB; Ribeiro RP; Colle D; Peres KC; Hermes J; Barbosa AM; Dafré AL; de Bem AF; Kuca K; Farina M
    Neurotoxicology; 2011 Dec; 32(6):888-95. PubMed ID: 21723318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase inhibition by aluminium phosphide poisoning in rats and effects of atropine and pralidoxime chloride.
    Mittra S; Peshin SS; Lall SB
    Acta Pharmacol Sin; 2001 Jan; 22(1):37-9. PubMed ID: 11730559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography-tandem mass spectrometry method for determination of the pyridinium aldoxime 4-PAO in brain, liver, lung, and kidney.
    Sakurada K; Ohta H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(17-18):1414-9. PubMed ID: 20138594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the therapeutic effect of 2-pyridine aldoxime methiodide (2-PAM) in mammals following organophosphorus compound (OP)-poisoning (report II): aging of OP-inhibited mammalian cholinesterase.
    Uehara S; Hiromori T; Suzuki T; Kato T; Miyamoto J
    J Toxicol Sci; 1993 Aug; 18(3):179-83. PubMed ID: 8246310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antidose therapy for organophosphate poisoning].
    Iseki K
    Chudoku Kenkyu; 2008 Apr; 21(2):151-9. PubMed ID: 18516940
    [No Abstract]   [Full Text] [Related]  

  • 19. Paraoxon has only a minimal effect on pralidoxime brain concentration in rats.
    Petroianu GA; Lorke DE; Hasan MY; Adem A; Sheen R; Nurulain SM; Kalasz H
    J Appl Toxicol; 2007; 27(4):350-7. PubMed ID: 17265425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of continuous infusion pralidoxime in children with organophosphate poisoning.
    Schexnayder S; James LP; Kearns GL; Farrar HC
    J Toxicol Clin Toxicol; 1998; 36(6):549-55. PubMed ID: 9776957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.